Tokyo Medical and Dental University (TMDU) is introducing Eyerising’s myopia management device as a treatment option for its myopia patients.
The prestigious institution has a rich history of excellence, and is committed to fostering innovation and improving health outcomes through cutting-edge research and clinical practice.
The Eyerising myopia management device uses patented repeated low-level red-light (RLRL) technology, offering an efficacious, non-invasive, and user-friendly solution for managing myopia in patients.
